Home
Conditions
Recurrence

Clinical trial condition

Recurrence

Explore clinical trials studying Recurrence. Study availability and eligibility vary by location and protocol.

2,312 public trials 521 recruiting studies

Refine in advanced search Browse all conditions

Recurrence trial results

Not Yet Recruiting

A Phase 1/2 Study to Evaluate the Safety and Efficacy of Dibotatug (DR-01) in Adults With Bone Marrow Failure Syndromes

NCT07712562

Conditions: Anemia, Anemia, Aplastic, Aplastic Anemias, +16 more
Locations: Dren Investigational Site Duarte, California, United States

Dren Investigational Site Palo Alto, California, United States

Dren Investigational Site Miami, Florida, United States

Dren Investigational Site Atlanta, Georgia, United States

View Trial Details

Not Yet Recruiting

Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

NCT07725406

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +23 more
Locations: Weill Cornell Medicine/NewYork-Presbyterian Hospital New York, United States

View Trial Details

Not Yet Recruiting

S243249 Monotherapy in Patients With Relapsed or Refractory Acute Leukemia With a KMT2A or NUP98 Translocation or Relapsed or Refractory AML With NPM1c Mutation

NCT07722312

Conditions: Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

ML-016 in Advanced Cancer With Lung and/or Liver Involvement

NCT07723482

Conditions: Advanced Solid Tumor With Lung and/or Liver Involvement, Disease Attributes, Neoplasm Metastasis, +5 more
Locations: Southside Cancer Care Centre Miranda, New South Wales, Australia

Illawarra Cancer Care Center, Wollongong Hospital Wollongong, New South Wales, Australia

Sunshine Coast Haematology and Oncology Clinic Buderim, Queensland, Australia

View Trial Details

Not Yet Recruiting

GLORY: Glofit-GemOx With Liso-Cel For Lymphoma

NCT07711483

Conditions: B-Cell Lymphomas, Disease Attributes, Hemic and Lymphatic Diseases, +14 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

View Trial Details

Not Yet Recruiting

Sacituzumab Tirumotecan in Recurrent/Metastatic Adenoid Cystic Carcinoma and Papillary Thyroid Carcinoma (STRAP)

NCT07521670

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Adenoid Cystic Carcinoma Metastatic, +20 more
Locations: National Cancer Center Hospital Tokyo, Japan

Sarawak General Hospital Kuching, Sarawak, Malaysia

University of Malaya Medical Center Kuala Lumpur, Malaysia

National Cancer Centre Singapore Singapore

View Trial Details

Not Yet Recruiting

A Phase II Trial for MOR Antagonism With Axelopran to Enhance Immunotherapy in Head and Neck Cancer

NCT07662720

Conditions: Carcinoma, Carcinoma, Squamous Cell, Disease Attributes, +12 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

LASER VERSUS CRYSTALLIZED PHENOL IN PILONIDAL SINUS DISEASE

NCT07701772

Conditions: Disease Attributes, Neurologic Manifestations, Pain, +8 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study of Polatuzumab Vedotin and Glofitamab in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma Within 12 Months After R-CHOP

NCT07702851

Conditions: Diffuse Large B-cell Lymphoma, Disease Attributes, Hemic and Lymphatic Diseases, +13 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma

NCT07695740

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Beijing Chao-yang Hospital, Capital Medical University Beijing, Beijing Municipality, China

View Trial Details

Recurrence

Recurrence trial results

Related conditions